"Food-Drug Interactions" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The pharmacological result, either desirable or undesirable, of drugs interacting with components of the diet. (From Stedman, 25th ed)
| Descriptor ID |
D018565
|
| MeSH Number(s) |
G07.690.773.968.511
|
| Concept/Terms |
Food-Drug Interactions- Food-Drug Interactions
- Food Drug Interactions
- Food-Drug Interaction
- Interaction, Food-Drug
- Interactions, Food-Drug
- Drug-Food Interactions
- Drug Food Interactions
- Drug-Food Interaction
- Interaction, Drug-Food
- Interactions, Drug-Food
Food Interactions- Food Interactions
- Food Interaction
- Interaction, Food
- Interactions, Food
|
Below are MeSH descriptors whose meaning is more general than "Food-Drug Interactions".
Below are MeSH descriptors whose meaning is more specific than "Food-Drug Interactions".
This graph shows the total number of publications written about "Food-Drug Interactions" by people in this website by year, and whether "Food-Drug Interactions" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Food-Drug Interactions" by people in Profiles.
-
Story G, Lee J, Cohen G, Rani A, Doherty J, Sela DA. Impact of Dietary Fat and Oral Delivery System on Cannabigerol Pharmacokinetics in Adults. Cannabis Cannabinoid Res. 2024 Dec; 9(6):1543-1555.
-
Walker ME, Matthan NR, Solano-Aguilar G, Jang S, Lakshman S, Molokin A, Faits T, Urban JF, Johnson WE, Lamon-Fava S, Lichtenstein AH. A Western-type dietary pattern and atorvastatin induce epicardial adipose tissue interferon signaling in the Ossabaw pig. J Nutr Biochem. 2019 05; 67:212-218.
-
Patnaik A, Tolcher A, Beeram M, Nemunaitis J, Weiss GJ, Bhalla K, Agrawal M, Nichols G, Middleton S, Beryozkina A, Sarapa N, Peck R, Zhi J. Clinical pharmacology characterization of RG7112, an MDM2 antagonist, in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2015 Sep; 76(3):587-95.
-
Andrews-Chavez JY, Lee CS, Houser RF, Falcon LM, Tucker KL. Factors associated with alcohol consumption patterns in a Puerto Rican urban cohort. Public Health Nutr. 2015 Feb; 18(3):464-73.
-
McClements DJ. Utilizing food effects to overcome challenges in delivery of lipophilic bioactives: structural design of medical and functional foods. Expert Opin Drug Deliv. 2013 Dec; 10(12):1621-32.
-
Goldberg SL, Giardina PJ, Chirnomas D, Esposito J, Paley C, Vichinsky E. The palatability and tolerability of deferasirox taken with different beverages or foods. Pediatr Blood Cancer. 2013 Sep; 60(9):1507-12.
-
Tucker KL. Assessment of usual dietary intake in population studies of gene-diet interaction. Nutr Metab Cardiovasc Dis. 2007 Feb; 17(2):74-81.
-
Oki T, Usami Y, Nakai M, Sagisaka M, Ito H, Nagaoka K, Mamiya N, Yamanaka K, Utsumi M, Kaneda T. Pharmacokinetics of lopinavir after administration of Kaletra in healthy Japanese volunteers. Biol Pharm Bull. 2004 Feb; 27(2):261-5.